Rehabilitation Equipment Market Set To Grow To $13.06 Bn By 2021

08 August 2018
Pharma

Visiongain has launched a new Pharmaceutical Report Global Rehabilitation Equipment Market 2017-2027: Revenue Forecasts for Rehabilitation Equipment, Daily Living Aids, Mobility Equipment, Body Support Devices and Exercise Equipment

The report forecasts the rehabilitation equipment market will multiply in revenues from 2017 to 2027. The pharmaceutical segment is evolving. Visiongain reports the strength of the rehabilitation equipment market is its daily living aids segment, which generated revenues of $3.42bn. Rising prevalence of severe disabling conditions and rising number of people living with disability are the prime factors that support the growth of the rehabilitation equipment globally. According to World Health Organization, the prevalence of disability among populations has increased by 25% since 2005. This, steep increase in this patient population segment propels the use of rehabilitation equipment. In addition, prevalence of non-communicable diseases, rising incidence of disabilities and favourable healthcare reforms in developing countries and increasing awareness will drive the growth of the rehabilitation equipment market

The global rehabilitation equipment market is expected to grow owing to factors such as increasing disposable income coupled with favourable government policies in developed countries to meet the needs of geriatric and physically challenged population. In addition, increasing healthcare awareness and healthcare infrastructure development in the developing economies will drive the growth of the rehabilitation equipment market.
Technological advancements and increasing healthcare awareness among the patient population are some of the prominent factors that are expected to support the growth of the global rehabilitation equipment market during the forecast period from 2016 to 2027.” - Visiongain medical devices industry analyst

The new report shows revenue forecasts to 2027 at overall world market, submarket, product and national level. It forecasts these world-level submarkets:

• Daily Living Aids
• Mobility Equipment
• Body Support Devices
• Exercise Equipment

This investigation predicts revenues of ten leading products in the market, including Medical beds, Reading, Writing and Computing Aids, Bathroom and Toilet Assist Devices, Wheelchairs and Scooters, Walking Assist Devices, Medical Lifting Sling, Patient Lifts, Lower Body Exercise Equipment, Upper Body Exercise Equipment and Total Body Exercise Equipment.
Revenue forecasts are also included of Research, data and analyses covering activities of Carex Health Brands, Caremax, Drive DeVilbiss Healthcare, Dynatronics Corporation, GF Health Products, Inc.,Hospital Equipment Manufacturing Company, Invacare Coporation, Medline Industries, Inc, Roma Medical Aids.

Analyses cover R&D and commercial news and predicts revenues to 2027 in leading regional markets. This includes the US, Japan, Germany, the UK, France, Italy, Spain (EU5 group), Brazil, Russia, India, China and South Korea.

Global rehabilitation Equipment Market 2017-2027 adds to visiongain’s range of reports on industries and markets in healthcare. Together these studies cover medical devices, diagnostics and pharmaceuticals.

Leading companies featured in the report who are developing rehabilitation equipment include Carex Health Brands, Caremax, Drive DeVilbiss Healthcare, Dynatronics Corporation, GF Health Products, Inc.,Hospital Equipment Manufacturing Company, Invacare Coporation, Medline Industries, Inc, Roma Medical Aids.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2021-2031

Increasing demand for medical products in developing as well developed economies coupled with rising ageing population is expected to open new opportunities for medical device contract manufacturing industry over the forecast period.

01 December 2020

Read

Visiongain Publishes Virus Testing Diagnostic Kits Market Report 2021-2031

With the growing burden of rare diseases around the world, there has been a rise in the requirement for proper diagnosis as well as full proof treatment positions for various chronic diseases. With increasing awareness regarding symptoms of various terminal illnesses, the diagnosis rates have been improving in developing countries such as China, India, Japan, Brazil, and other southeast Asian countries.

01 December 2020

Read

Visiongain Publishes RNA Analysis/Transcriptomics Market Report 2020-2030

Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.

30 November 2020

Read

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever